Gene · 10381
Papers4,386
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,386
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TUBB3 R262H in a neonate with ptosis and vocal cord palsy. | Clin Dysmorphol | 2025 | 40073207 | PubTator, text mining | PubMed |
| Magnetically reshapable 3D multi-electrode arrays of liquid metals for electrophysiological analysis of brain organoids. | Nat Commun | 2025 | 40016200 | PubTator, text mining | PubMed |
| Enhanced Differentiation of Human Neural Stem Cells into Cortical Neurons Using 3D Chitosan Scaffolds. | ACS Appl Bio Mater | 2025 | 40012088 | PubTator, text mining | PubMed |
| Involvement of Nerve Growth Factor in the Reparative Reaction to Osteonecrotic Lesions. | J Orthop Res | 2025 | 39930333 | PubTator, text mining | PubMed |
| RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic-nuclear shuttling in human triple-negative breast cancer. | Clin Transl Med | 2025 | 39915011 | PubTator, text mining | PubMed |
| Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma Neurospheres. | Cells | 2025 | 39851500 | PubTator, text mining | PubMed |
| METTL3 promotes osteogenesis by regulating N6-methyladenosine-dependent primary processing of hsa-miR-4526. | Stem Cells | 2025 | 39756402 | PubTator, text mining | PubMed |
| LncRNA FIRRE drives gastric cancer progression via ZFP64-mediated TUBB3 promoter activation. | Cancer Lett | 2025 | 39706253 | PubTator, text mining | PubMed |
| Identification of TUBB3 as an immunotherapy target in lung cancer by genome wide in vivo CRISPR screening. | Neoplasia | 2025 | 39671912 | PubTator, text mining | PubMed |
| KIF21A-associated peripheral neuropathy defined by impaired binding with TUBB3. | J Med Genet | 2025 | 39643435 | PubTator, text mining | PubMed |
| The significance of exosomal non-coding RNAs (ncRNAs) in the metastasis of colorectal cancer and development of therapy resistance. | Gene | 2025 | 39643147 | PubTator, text mining | PubMed |
| Expanding the TUBB3-Related Phenotypic Landscape: Fetal Diagnosis of Novel TUBB3 Variant Linked With Phenotypic Variability Within a Single Family. | Prenat Diagn | 2025 | 39625365 | PubTator, text mining | PubMed |
| The important role of the Wnt/β-catenin signaling pathway in small molecules mediated gingival mesenchymal stem cells transdifferentiate into neuron-like cells. | Arch Oral Biol | 2025 | 39488928 | PubTator, text mining | PubMed |
| Combination therapy using Cel-CSO/Taxol NPs for reversing drug resistance in breast cancer through inhibiting PI3K/AKT/NF-κB/HIF-1α pathway. | Drug Deliv Transl Res | 2025 | 38922561 | PubTator, text mining | PubMed |
| Novel anoikis-related diagnostic biomarkers for aortic dissection based on machine learning. | Sci Rep | 2024 | 39732886 | PubTator, text mining | PubMed |
| Publisher Correction: Novel laser model of optic nerve transection provides valuable insights about the dynamics of optic nerve regeneration. | Sci Rep | 2024 | 39614091 | PubTator, text mining | PubMed |
| High Intraocular Concentration of Fibrinogen Regulates Retinal Function Via the ICAM-1 Pathway. | Invest Ophthalmol Vis Sci | 2024 | 39546292 | PubTator, text mining | PubMed |
| Organoids and organoid extracellular vesicles-based disease treatment strategies. | J Nanobiotechnology | 2024 | 39506799 | PubTator, text mining | PubMed |
| Retraction of: Exosomal miR-200c suppresses chemoresistance of docetaxel in tongue squamous cell carcinoma by suppressing TUBB3 and PPP2R1B. | Aging (Albany NY) | 2024 | 39485388 | PubTator, text mining | PubMed |
| Effects of mesenchymal stromal cells and human recombinant Nerve Growth Factor delivered by bioengineered human corneal lenticule on an innovative model of diabetic retinopathy. | Front Endocrinol (Lausanne) | 2024 | 39473506 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10381/papers?page=8